4-Cholesten-3-one

4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.

Cross Reference

Introduction

To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 4-Cholesten-3-one?

4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 4-Cholesten-3-one

Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 4-Cholesten-3-one?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 4-Cholesten-3-one?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 4-Cholesten-3-one?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 4-Cholesten-3-one?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 4-Cholesten-3-one

Download all related citations
Per page 10 20 50 100 | Total 397
Authors Title Published Journal PubMed Link
Palusinski R and Barud W Proscar and propecia--a therapeutic perspective. 2004 J. Clin. Endocrinol. Metab. pmid:15579805
Mathur S et al. Evaluation of cell permeation of a potent 5alpha-reductase inhibitor using MALDI-TOF MS. 2004 J Enzyme Inhib Med Chem pmid:15648657
Festuccia C et al. Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. 2005 J. Cancer Res. Clin. Oncol. pmid:15650886
Bairamov AA and Sapronov NS Effect of dehydroepiandrosterone on radioligand binding of [3H]-testosterone by androgen receptors in rat hypothalamus. 2004 Bull. Exp. Biol. Med. pmid:15665952
McVey MJ et al. Altered testicular microsomal steroidogenic enzyme activities in rats with lifetime exposure to soy isoflavones. 2004 J. Steroid Biochem. Mol. Biol. pmid:15698548
Pérez-Ornelas V et al. New 5alpha-reductase inhibitors: in vitro and in vivo effects. 2005 Steroids pmid:15763601
Souverein PC et al. Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: a population-based cohort study in the Netherlands. 2005 Eur. Urol. pmid:15774250
Panter BU et al. 5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activity. 2005 Mol. Cell. Biochem. pmid:15792368
Evans CP et al. An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases. 2005 BJU Int. pmid:15794775
Iranmanesh A and Veldhuis JD Combined inhibition of types I and II 5 alpha-reductase selectively augments the basal (nonpulsatile) mode of testosterone secretion in young men. 2005 J. Clin. Endocrinol. Metab. pmid:15811930